Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2025 Feb 12:16:1555559.
doi: 10.3389/fimmu.2025.1555559. eCollection 2025.

Commentary: Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of the Meet-Uro 15 study

Martina Catalano  1 , Sara Elena Rebuzzi  2 , Giuseppe Fornarini  3 , Giandomenico Roviello  1
Affiliations
Comment

Commentary: Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of the Meet-Uro 15 study

Martina Catalano et al. Front Immunol. .
No abstract available

Keywords: bone metastases; efficacy outcomes; immunotherapy; renal cell carcinoma; sodium levels.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study.
    Catalano M, Rebuzzi SE, Maruzzo M, De Giorgi U, Buti S, Galli L, Fornarini G, Zucali PA, Claps M, Chiellino S, Zampiva I, Pipitone S, Ricotta R, Sorarù M, Mollica V, Tudini M, Fratino L, Prati V, Caffo O, Atzori F, Morelli F, Prati G, Nolè F, Vignani F, Cavo A, Di Napoli M, Malgeri A, Naglieri E, Signori A, Banna GL, Rescigno P, Cerbone L, Antonuzzo L, Roviello G. Catalano M, et al. Front Immunol. 2024 Jul 5;15:1361010. doi: 10.3389/fimmu.2024.1361010. eCollection 2024. Front Immunol. 2024. PMID: 39034992 Free PMC article.

References

    1. Catalano M, Rebuzzi SE, Maruzzo M, De Giorgi U, Buti S, Galli L, et al. . Sodium levels and outcomes in patients with metastatic renal cell carcinoma receiving nivolumab. JAMA Netw Open. (2023) 6(11):e2345185. doi: 10.1001/jamanetworkopen.2023.45185 - DOI - PMC - PubMed
    1. Catalano M, Rebuzzi SE, Maruzzo M, De Giorgi U, Buti S, Galli L, et al. . Sodium levels and immunotherapy efficacy in MRCC patients with bone metastases: sub analysis of meet-uro 15 study. Front Immunol. (2024) 15:1361010. doi: 10.3389/FIMMU.2024.1361010 - DOI - PMC - PubMed
    1. Mezquita L, Auclin E, Ferrara R, Charrier M, Remon J, Planchard D, et al. . Association of the lung immune prognostic index with immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancer. JAMA Oncol. (2018) 4:351–7. doi: 10.1001/JAMAONCOL.2017.4771 - DOI - PMC - PubMed

LinkOut - more resources